Bayesian Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,087	Closed	-$307K	–	665
2024 Q4	$307K	Buy	+6,087	New	+$319K	0.04%	481
2024 Q2	–	Sell	-27,923	Closed	-$703K	–	803
2024 Q1	$703K	Buy	+27,923	New	+$660K	0.07%	370
2023 Q4	–	Sell	-12,409	Closed	-$338K	–	798
2023 Q3	$338K	Buy	+12,409	New	+$359K	0.04%	446
2020 Q4	–	Sell	-28,057	Closed	-$488K	–	487
2020 Q3	$488K	Buy	+28,057	New	+$447K	0.12%	231
2020 Q2	–	Sell	-19,400	Closed	-$231K	–	562
2020 Q1	$231K	Buy	19,400 +6,701	+53%	+$82.9K	0.05%	541
2019 Q4	$154K	Buy	+12,699	New	+$177K	0.03%	552
2017 Q4	–	Sell	-14,700	Closed	-$284K	–	577
2017 Q3	$284K	Buy	+14,700	New	+$219K	0.07%	376